financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Buy Opinion On Shares Of Sba Communications Corporation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Buy Opinion On Shares Of Sba Communications Corporation
Apr 30, 2024 7:29 AM

10:10 AM EDT, 04/30/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We trim our target price by $2 to $230, on a forward EV/EBITDA of 19.5x our 2024 EBITDA estimate, a discount to SBAC's 10-year average multiple (23.5x) given slower growth projections as customer capex remains muted given the higher interest rate environment. We trim our 2024 AFFO estimate by $0.07 to $13.34 and lower 2025's by $0.43 to $13.44. SBAC reported Q1 2024 AFFO of $3.29 vs. $3.12, in line with consensus. Revenues dropped 3% Y/Y as same-tower organic leasing revenue growth remained healthy but slowed to 2.5% Y/Y (6.3% excluding churn) vs. 4.7% Y/Y (8.9%) in Q1 2023. Leasing remained stronger internationally, where growth was 3.3% Y/Y (8.1%) compared to 2.3% Y/Y (5.9%) domestically. SBAC continues to focus on lowering its leverage profile given elevated interest rates, with net leverage of 6.5x vs. 6.9x Y/Y and variable rate debt at 4% of total debt. We believe valuation is attractive, with shares trading at 17.9x our 2024 EV/EBITDA estimate, a 23% discount to their 10-year average multiple.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Sell Opinion On Shares Of Mccormick & Company, Incorporated
Research Alert: CFRA Keeps Sell Opinion On Shares Of Mccormick & Company, Incorporated
Oct 7, 2025
02:30 PM EDT, 10/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target by $1 to $59, about 19x our FY 26 (Nov.) EPS estimate of $3.12 (down from $3.14; FY 25 raised to $3.03 from $2.97). This...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Constellation Brands Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Constellation Brands Inc.
Oct 7, 2025
11:50 AM EDT, 10/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target by $10 to $175, based on a 2027 P/E of 13.7x, a steep but justified discount to STZ's 10-year average forward P/E of 21.6x. We...
Research Alert: CFRA Lowers Opinion On Real Estate To Underweight From Marketweight
Research Alert: CFRA Lowers Opinion On Real Estate To Underweight From Marketweight
Oct 8, 2025
02:20 PM EDT, 10/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We are lowering our opinion on the Real Estate sector to underweight given its vulnerability to potential disappointment if Fed rate cuts prove less aggressive than market expectations, combined with...
Research Alert: CFRA Raises Opinion On Health Care To Marketweight From Underweight
Research Alert: CFRA Raises Opinion On Health Care To Marketweight From Underweight
Oct 8, 2025
01:40 PM EDT, 10/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: After Pfizer Inc. (PFE 26 ****) and the U.S. government struck the first Most Favored Nation (MFN) drug pricing deal to lower drug prices in the U.S., we see policy...
Copyright 2023-2026 - www.financetom.com All Rights Reserved